Watch Ticker

Zentalis Pharmaceuticals, Inc. Common Stock

Go to Zentalis Pharmaceuticals, Inc. Common Stock Website

$1.35

-0.05 (-3.90%)

Live

Previous Close

$1.41

Day Range

$1.35 - $1.41

Previous Day Range

$1.39 - $1.45

Market Cap

$100.0 million USD

Day Vol.

140815

Previous Day Vol.

492076

Currency

USD

Primary Exchange

Nasdaq

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Aron Feingold - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals granted 14,000 stock options to a newly hired employee under its 2022 Employment Inducement Incentive Award Plan, with options vesting over four years at an exercise price of $1.19 per share.

Related tickers: ZNTL.

Read Full Article

N/A - Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Zentalis Pharmaceuticals granted stock options to four newly hired employees as an inducement to join the company. The options have a 10-year term and will vest over four years.

Related tickers: ZNTL.

Read Full Article

Trending Tickers

Please sign in to view